Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01023906 · ClinicalTrials.gov registry record

Taste Perception and Chronic Disease Risk

A clinical trial of Obesity and Diabetes, sponsored by Tufts University.

Completed
Registry status
90
Enrollment target
1
Study location

NCT01023906: Completed study of Obesity and Diabetes, sponsored by Tufts University.

NCT01023906 is a study of Obesity and Diabetes that has completed, run by Tufts University. The registered enrollment target is 90 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01023906, a study of Obesity and Diabetes, has completed, sponsored by Tufts University.

COMPLETED
Registry status
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of the Taste Perception Study is to assess variations in the ability to taste and perceive sensations from various stimuli in younger (18-49 years) and older (50-85 years) volunteers. The study's goal is to determine how these sensations influence what one likes to eat, and what one chooses to eat, and whether there is an association with dietary intake, body composition and chronic disease. Another objective of the study is to determine the association between variations in oral sensations and genes mediating sensory perception and dietary behaviours.

Study Locations (1)

Massachusetts

  • Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University - Boston

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2008-07
Est. Completion 2010-03
Tufts University

163 total trials

What the finished NCT01023906 record still lists

NCT01023906 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (89% lower).

The record links to 5 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.

NCT01023906 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01023906 about?

NCT01023906 is a clinical study titled "Taste Perception and Chronic Disease Risk". The purpose of the Taste Perception Study is to assess variations in the ability to taste and perceive sensations from various stimuli in younger (18-49 years) and older (50-85 years) volunteers. The study's goal is to determine how these sensations influence what one likes to eat, and what one choo...

What is the current status of trial NCT01023906?

This trial is currently completed. The enrollment target is 90 participants. The study started on 2008-07. Estimated completion is 2010-03.

What conditions does trial NCT01023906 study?

This clinical trial studies the following conditions: Obesity, Diabetes, Aging, Cardiovascular Disease, Metabolic Syndrome.

Who is sponsoring clinical trial NCT01023906?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01023906 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01023906's enrollment target sits among peer trials

90 520th of 1053 higher than 526 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01023906, the US trial registry maintained by the National Library of Medicine. NCT01023906 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.